How common AF-risk loci (for example, PITX2) and rare cardiomyopathy variants modulate the probability and pace of recovery is unclear, as is the interaction between inherited substrate and AF-burden-driven injury. This evidence concerns the gene PITX2 and atrial fibrillation.